Reduction of Plasma Sodium Overcorrection for Severe Hyponatremia Patients
Care Process & Redesign
National Healthcare Group Quality Improvement
National Healthcare Group
31 December 2022
To reduce the proportion of plasma sodium overcorrection for severe hyponatremia patients from 44% to below 25%. Sustained adherence to protocols significantly reduced adverse events and associated costs.
Year Submitted: 2022
Published Date: 31 December 2022
Tags: Care Process ＆ Redesign, Risk Management, Adverse Outcome Reduction
About this Content
Aims
To reduce the proportion of plasma sodium overcorrection for severe hyponatremia patients from 44% to below 25%.
Background
Overcorrection of plasma sodium leads to adverse outcomes, necessitating better risk management.
Methods
Developed clinical guidelines, implemented monitoring tools, and integrated workflows across departments.
Results
Reduced overcorrection rates to 32.1%, achieving an annual cost savings of $260,676.
Conclusion
Sustained adherence to protocols significantly reduced adverse events and associated costs.
Lessons Learnt
Interdepartmental collaboration and clear workflows improve adherence and patient outcomes.
Additional Information
NHG Quality Day 2022: Merit Award.
Keywords
Hyponatremia, Plasma Sodium, Risk Management
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | National Healthcare Group |
Organization(s) Involved | Tan Tock Seng Hospital |
Platform(s) | National Healthcare Group Quality Improvement |
Healthcare Professional Group(s) | Allied Health, Medical |
Applicable Specialty or Discipline | Medical ＆ Laboratory Technology |
Project Lead(s) | Huang Wenhui |
Project Member(s) | Ang Joo Shiang |
Connect with this contributor!
Dr Huang Wenhui - Wenhui_HUANG@ttsh.com.sg